Cooperative interaction between ERα and the EMT-inducer ZEB1 reprograms breast cancer cells for bone metastasis

被引:0
作者
Nastaran Mohammadi Ghahhari
Magdalena K. Sznurkowska
Nicolas Hulo
Lilia Bernasconi
Nicola Aceto
Didier Picard
机构
[1] Université de Genève,Département de Biologie Cellulaire
[2] Sciences III,Department of Biology
[3] Institute of Molecular Health Sciences,Institute of Genetics and Genomics of Geneva
[4] ETH Zurich,undefined
[5] Université de Genève,undefined
来源
Nature Communications | / 13卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The epithelial to mesenchymal transition (EMT) has been proposed to contribute to the metastatic spread of breast cancer cells. EMT-promoting transcription factors determine a continuum of different EMT states. In contrast, estrogen receptor α (ERα) helps to maintain the epithelial phenotype of breast cancer cells and its expression is crucial for effective endocrine therapies. Determining whether and how EMT-associated transcription factors such as ZEB1 modulate ERα signaling during early stages of EMT could promote the discovery of therapeutic approaches to suppress metastasis. Here we show that, shortly after induction of EMT and while cells are still epithelial, ZEB1 modulates ERα-mediated transcription induced by estrogen or cAMP signaling in breast cancer cells. Based on these findings and our ex vivo and xenograft results, we suggest that the functional interaction between ZEB1 and ERα may alter the tissue tropism of metastatic breast cancer cells towards bone.
引用
收藏
相关论文
共 210 条
[1]  
Lin C-Y(2004)Discovery of estrogen receptor α target genes and response elements in breast tumor cells Genome Biol. 5 1141-1154
[2]  
Siersbaek R(2018)Signaling pathways and steroid receptors modulating estrogen receptor α function in breast cancer Genes Dev. 32 631-643
[3]  
Kumar S(2009)Biological determinants of endocrine resistance in breast cancer Nat. Rev. Cancer 9 bqaa224-78
[4]  
Carroll JS(2021)Genome-wide estrogen receptor activity in breast cancer Endocrinology 162 65-352
[5]  
Musgrove EA(2019)Phenotypic plasticity: driver of cancer initiation, progression, and therapy resistance Cell Stem Cell 24 341-7362
[6]  
Sutherland RL(2020)Guidelines and definitions for research on epithelial–mesenchymal transition Nat. Rev. Mol. Cell. Biol. 21 7353-84
[7]  
Farcas AM(2019)Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells Proc. Natl Acad. Sci. USA 116 69-629
[8]  
Nagarajan S(2019)New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer Nat. Rev. Mol. Cell. Biol. 20 611-695
[9]  
Cosulich S(2017)EMT, CSCs, and drug resistance: the mechanistic link and clinical implications Nat. Rev. Clin. Oncol. 14 681-2098
[10]  
Carroll JS(2018)EMT subtype influences epithelial plasticity and mode of cell migration Dev. Cell 45 2085-494